Diagnostic and Staging Value of Inter-Alpha-Trypsin Inhibitor Heavy Chain Family Member 4, Neutrophil Gelatinase-Associated Lipocalin, and Fibronectin Type III Domain-Containing Protein 5 as Non-Invasive Biomarkers for Endometriosis

In: Medical Science Journal for Advance Research · 2026 · vol. 7(3) · doi:10.46966/msjar.v7i3.446 · W7217363580
OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-26 ⓘ

Serum ITIH4, NGAL, and FNDC5 levels significantly differ in women with endometriosis compared to healthy controls, demonstrating high diagnostic accuracy and utility for disease staging as non-invasive biomarkers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-18 · read from full text ⓘ

This case-control study evaluated serum levels of ITIH4, NGAL, and FNDC5 in 50 women with surgically confirmed endometriosis compared to 50 healthy controls. The results showed significantly elevated ITIH4 and NGAL alongside reduced FNDC5 in the patient group, with high area under the curve values indicating strong diagnostic accuracy for distinguishing cases from controls. These biomarkers also demonstrated substantial utility in staging disease severity according to the revised American Society for Reproductive Medicine classification, particularly when used in combination. This paper is centrally about endometriosis — specifically the evaluation of non-invasive serum biomarkers for diagnosis and staging.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis remains a diagnostic challenge owing to the reliance on invasive surgical confirmation. The identification of reliable serum biomarkers could facilitate earlier, non-invasive diagnosis and staging. This study aimed to evaluate the diagnostic and staging value of serum inter-alpha-trypsin inhibitor heavy chain family member 4 (ITIH4), neutrophil gelatinase-associated lipocalin (NGAL), and fibronectin type III domain-containing protein 5 (FNDC5) in women with endometriosis. Methods: This case–control study included 100 women: 50 with surgically confirmed endometriosis (27 stage I–II and 23 stage III–IV according to the revised American Society for Reproductive Medicine classification) and 50 age-matched healthy controls. Serum levels of ITIH4, NGAL, and FNDC5 were measured using ELISA. Results: Serum ITIH4 and NGAL levels were significantly elevated in the endometriosis group compared with controls (43.60 ± 11.96 vs. 14.30 ± 2.74 ng/mL; and 135.69 ± 41.89 vs. 41.02 ± 5.82 ng/mL, respectively; both p < 0.001), whilst FNDC5 was significantly reduced (4.17 ± 1.45 vs. 8.44 ± 1.23 ng/mL, p < 0.001). For diagnosis, the AUC values were 0.998 for ITIH4, 0.954 for FNDC5, and 0.984 for CA-125. For staging, FNDC5 achieved an AUC of 0.965, ITIH4 achieved 0.916, and NGAL achieved 0.794. The combined biomarker panel yielded an AUC of 0.995 for staging. Conclusion: Serum ITIH4, NGAL, and FNDC5 demonstrate excellent diagnostic and staging performance for endometriosis and may serve as promising non-invasive biomarkers to complement current diagnostic approaches.
Full text 3,962 characters · extracted from oa-doi-fallback · click to expand
Diagnostic and Staging Value of Inter-Alpha-Trypsin Inhibitor Heavy Chain Family Member 4, Neutrophil Gelatinase-Associated Lipocalin, and Fibronectin Type III Domain-Containing Protein 5 as Non-Invasive Biomarkers for Endometriosis DOI: https://doi.org/10.46966/msjar.v7i3.446Keywords: Endometriosis; ITIH4; NGAL; FNDC5; Non-invasive diagnosis; Staging; rASRMAbstract Background: Endometriosis remains a diagnostic challenge owing to the reliance on invasive surgical confirmation. The identification of reliable serum biomarkers could facilitate earlier, non-invasive diagnosis and staging. This study aimed to evaluate the diagnostic and staging value of serum inter-alpha-trypsin inhibitor heavy chain family member 4 (ITIH4), neutrophil gelatinase-associated lipocalin (NGAL), and fibronectin type III domain-containing protein 5 (FNDC5) in women with endometriosis. Methods: This case–control study included 100 women: 50 with surgically confirmed endometriosis (27 stage I–II and 23 stage III–IV according to the revised American Society for Reproductive Medicine classification) and 50 age-matched healthy controls. Serum levels of ITIH4, NGAL, and FNDC5 were measured using ELISA. Results: Serum ITIH4 and NGAL levels were significantly elevated in the endometriosis group compared with controls (43.60 ± 11.96 vs. 14.30 ± 2.74 ng/mL; and 135.69 ± 41.89 vs. 41.02 ± 5.82 ng/mL, respectively; both p < 0.001), whilst FNDC5 was significantly reduced (4.17 ± 1.45 vs. 8.44 ± 1.23 ng/mL, p < 0.001). For diagnosis, the AUC values were 0.998 for ITIH4, 0.954 for FNDC5, and 0.984 for CA-125. For staging, FNDC5 achieved an AUC of 0.965, ITIH4 achieved 0.916, and NGAL achieved 0.794. The combined biomarker panel yielded an AUC of 0.995 for staging. Conclusion: Serum ITIH4, NGAL, and FNDC5 demonstrate excellent diagnostic and staging performance for endometriosis and may serve as promising non-invasive biomarkers to complement current diagnostic approaches. Downloads Published How to Cite Issue Section License Copyright (c) 2026 Muhammed Jassim, Banan Natiq Turkey This work is licensed under a Creative Commons Attribution 4.0 International License. In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that: - They are authorized by their co-authors to enter into these arrangements. - The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal. - That it is not under consideration for publication elsewhere, - The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out. - They secure the right to reproduce any material that has already been published or copyrighted elsewhere. - They agree to the following license and copyright agreement. License and Copyright Agreement Authors who publish with Medical Science Journal for Advance Research agree to the following terms: - Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. - Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal. - Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (24)

Source provenance

openalex
last seen: 2026-11-20T06:09:37.170340+00:00
License: CC0 · commercial use OK